The purpose of this Notice is to alert the community that NIH plans to publish four Funding Opportunity Annoucements (FOAs) as part of the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative to solicit research on COVID-19 diagnostic testing in underserved and vulnerable populations. The FOAs are expected to be published in early June, and we will accept applications through August 2020 for FY20 funding.The FOAs will be Requests for Applications (RFAs) and Notices of Special Interest (NOSIs) for competitive revisions. The goal is to make awards by September 2020.
This Notice is being provided to allow potential applicants additional time to develop responsive applications.
Research Initiative Details
The goal of RADx-UP is to reduce COVID-19 associated morbidity and mortality disparities for those vulnerable and underserved populations that are disproportionately affected by, have the highest infection rates of, and/or are most at risk for adverse outcomes from contracting the virus. This Notice encourages researchers to leverage partnerships with key stakeholders to conduct community-engaged research to understand COVID-19 disparities and to increase access and effectiveness of diagnostic testing interventions among underserved COVID-19 medically and/or socially vulnerable populations.
NIH plans to publish three NOSIs for competitive revision awards as follows:
- To solicit emergency competitive revision applications to existing awards for large consortia, multi-site trials, centers and other current networks that have adequate capacity, infrastructure, and established community-engaged relationships to support large-scale testing interventions or have the capacity to ramp up quickly to reach underserved or vulnerable populations.
- Similar to the above, but shifts eligibility to collaborative and individual research awards, generally focused on smaller underserved or vulnerable populations.
- To solicit research to understand the social, ethical, and behavioral implications (SEBI) of COVID-19 testing in these populations.
The fourth funding opportunity using the U24 activity code will be announced for a Coordination and Data Collection Center (CDCC), a key component of the consortium. The CDCC will serve as a national resource, working with NIH scientific staff and consortium members to provide overarching support and guidance in the following four domains: (1) Administrative Operations and Logistics, (2) COVID-19 Testing Technology, (3) Community and Health System Engagement and (4) Data Collection, Integration and Sharing.
The NIH intends for the awardees of the three NOSIs to serve as one consortium of interlinked, community-engaged, intervention projects across the United States (coordinated by the CDCC)to deploy implementation strategies to improve the reach, acceptance, uptake, and sustainability of COVID-19 testing and ultimately understand COVID-19 health disparities.
Applications are due July, 2020.